کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5722343 1608110 2017 8 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Research paperComparative effectiveness of dual-action versus single-action antidepressants for the treatment of depression in people living with HIV/AIDS
ترجمه فارسی عنوان
اثربخشی مقایسه ای از داروهای ضد افسردگی دو طرفه و تک اقدام برای درمان افسردگی در افراد مبتلا به اچ آی وی / ایدز
کلمات کلیدی
اچ آی وی / ایدز، افسردگی، داروهای ضد افسردگی، اثربخشی مقایسه ای، قسمت درمان جدید کاربر، وزنی احتمال معکوس،
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی روانپزشکی و بهداشت روانی
چکیده انگلیسی


- Dual-action and single-action antidepressants were compared in people with HIV.
- Both types of antidepressants are effective for depression in people with HIV.
- Both types of antidepressants are suitable 1st line treatments for people with HIV.
- Depression remission rates were lower than results observed in controlled trials.
- Comparisons of other health services for depression are needed in people with HIV.

BackgroundDepression is the most common psychiatric comorbidity among people living with HIV/AIDS (PLWHA). Little is known about the comparative effectiveness between different types of antidepressants used to treat depression in this population. We compared the effectiveness of dual-action and single-action antidepressants in PLWHA for achieving remission from depression.MethodsWe used data from the Centers for AIDS Research Network of Integrated Clinic Systems to identify 1175 new user dual-action or single-action antidepressant treatment episodes occurring from 2005 to 2014 for PLWHA diagnosed with depression. The primary outcome was remission from depression defined as a Patient Health Questionnaire-9 (PHQ-9) score <5. Mean difference in PHQ-9 depressive symptom severity was a secondary outcome. The main approach was an intent-to-treat (ITT) evaluation complemented with a per protocol (PP) sensitivity analysis. Generalized linear models were fitted to estimate treatment effects.ResultsIn ITT analysis, 32% of the episodes ended in remission for both dual-action and single-action antidepressants. The odds ratio (OR) of remission was 1.02 (95%CI=0.63,1.67). In PP analysis, 40% of dual-action episodes ended in remission compared to 32% in single-action episodes. Dual-action episodes had 1.33 times the odds of remission (95%CI=0.55,3.21), however the result was not statistically significant. Non-significant differences were also observed for depressive symptom severity.LimitationsMissing data was common but was addressed with inverse probability weights.ConclusionsResults suggest that single-action and dual-action antidepressants are equally effective in PLWHA. Remission was uncommon highlighting the need to identify health service delivery strategies that aid HIV providers in achieving full remission of their patients' depression.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Affective Disorders - Volume 215, June 2017, Pages 179-186
نویسندگان
, , , , , , , ,